The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The myeloma-developing regimens using genomics (MyDRUG) master protocol.
 
Daniel Auclair
No Relationships to Disclose
 
Kenneth Carl Anderson
Stock and Other Ownership Interests - C4 Therapeutics; OncoPep
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen Oncology; Millennium; Sanofi
Patents, Royalties, Other Intellectual Property - C4 Therapeutics; Oncopep
 
David Avigan
Employment - Parexel
Consulting or Advisory Role - Celgene; Seagen
Research Funding - Astex Pharmaceuticals; Genus Oncology; Pharmacyclics
 
Giada Bianchi
No Relationships to Disclose
 
Noa Biran
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Karyopharm Therapeutics (Inst); Merck (Inst)
 
Maria Chaudhry
No Relationships to Disclose
 
Hearn J. Cho
Honoraria - Genentech/Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Janssen Research & Development
Research Funding - Agenus; Bristol-Myers Squibb; Janssen Research & Development
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Maggie Furlong
No Relationships to Disclose
 
Craig C. Hofmeister
Consulting or Advisory Role - Adaptive biotechnologies; Celgene; Teva; Thrasos Therapeutics
Research Funding - Arno Therapeutics; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Takeda
Travel, Accommodations, Expenses - Amgen
 
Ankit J. Kansagra
No Relationships to Disclose
 
Amrita Y. Krishnan
Stock and Other Ownership Interests - Celgene (I); Kite, a Gilead company (I)
Consulting or Advisory Role - Celgene; Janssen Oncology; Kite, a Gilead company; Onyx; Seagen; Takeda
Speakers' Bureau - Celgene; Janssen Oncology; onyx; Takeda
Research Funding - Celgene (Inst); takeda (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen; Onyx; Takeda
 
Jeremy Todd Larsen
No Relationships to Disclose
 
Gregory Joshua Orloff
No Relationships to Disclose
 
Ravi Vij
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Dava Oncology; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
 
Peter Michael Voorhees
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Speakers' Bureau - Celgene
 
Andrew Jenho Yee
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Dexcel Pharma; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Jing Christine Ye
No Relationships to Disclose
 
Jeffrey A. Zonder
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen; Prothena; Seagen; Takeda
Research Funding - Celgene (Inst)
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Shaji Kumar
Honoraria - Dr. Reddy's
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)